Biotech

The New York Post reports that a coalition of biotech firms and university labs has announced a major breakthrough: using artificial intelligence to assist genome editing, the team has cultivated cells carrying key mammoth cold-tolerance gene traits, bringing the dream of resurrecting an extinct large mammal closer to reality.

The FDA has approved Regeneron’s Otarmeni, the world’s first dual AAV vector-based gene therapy for severe-to-profound sensorineural hearing loss caused by OTOF gene mutations, with 80% of patients showing hearing improvement in clinical trials.